Loading clinical trials...
Loading clinical trials...
Tranexamic acid (TA) inhibits fibrinolysis by binding to lysine binding-sites of plasminogen to fibrin. Fibrinolysis is stimulated by surgical trauma, and the administration of TA has been shown effec...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Rothman Institute Orthopaedics
NCT07556263 · Hip Fractures (ICD-10 72.01-72.2)
NCT07561164 · Hip Fracture Surgery, Mobility Limitation, and more
NCT05246813 · Osteoporosis, Osteoarthritis, Hip, and more
NCT07350044 · PENG Block, Hip Fracture Surgeries
NCT06565910 · Femoral Neck Fractures, Femur Head Necrosis, and more
Bryn Mawr Hospital
Bryn Mawr, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions